Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
Abstract Flavopiridol (FP) is a pan-cyclin dependent kinase inhibitor, which shows strong efficacy in inducing cancer cell apoptosis. Although FP is potent against most cancer cells in vitro, unfortunately it proved less efficacious in clinical trials in various aggressive cancers. To date, the mole...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/bc89935f75804aa4884f583426b81b31 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|